Symbiotic Treatment Improve IBS Symptoms and Quality of Life: Placebo-Controlled Study

Bazzi Nagham, Bazzi Mariam, Hallal Hadi, Lakkis Remie, Akoush Hassan, Saad Wajih, AlKhatib Amani, Hallal Mahmoud
2021 Acta Scientific Gastrointestinal Disorders  
Irritable bowel syndrome (IBS) is a chronic and functional gastrointestinal dysfunction characterized by altered bowel movement and abdominal pain and has a complicated etiology. Probiotics are the novel therapy based on better understanding of the disease pathology. Patients and Methods: We conducted a control-placebo study, 157 subjects enrolled in this study, and followed up for 6 months, divided into three groups to compare the effect of probiotics and placebo on IBS patients. Results:
more » ... otics significantly decreased the IBS symptoms, it normalized bowel movement. Conclusion: Probiotics could be the gold standard for IBS treatment.
doi:10.31080/asgis.2021.04.0230 fatcat:ucs4tty3dnfsbl7chicayfotpa